BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05008224-completion@plaintrial.com
DTSTAMP:20261029T013857Z
DTSTART;VALUE=DATE:20240526
SUMMARY:Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in P
 articipants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475
 -C11/KEYNOTE-C11) — estimated completion date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT05008224
URL:https://plaintrial.com/trial/NCT05008224
END:VEVENT
END:VCALENDAR